TRACON Pharmaceutical (TCON) – Management Comments
-
TRACON Pharmaceutical (TCON) Adds Lisa Johnson-Pratt, M.D. to Board
-
TRACON Pharmaceutical (TCON) Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TCON Stock Lookup